466-02-005 · Quantitative Applications in Body MRI: In Numbers We Trust
· Tuesday, 12 May, 9:15 AM–10:10 AM · Digital Posters Row G
Keywords:ProstateDiffusion-Weighted ImagingImage synthesisT1 and T2 mapping
Accepted
Yu Ueda 1, Tsutomu Tamada2, Atsushi Higaki2, Kazunori Moriya2, Shigeru Shibata2, Makoto Obara1, Masami Yoneyama1, Marc Van Cauteren1
1Philips Japan, Tokyo, Japan
2Department of Radiology, Kawasaki Medical School, Kurashiki, Japan
Presenting Author: Yu Ueda
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Ueda Y, Tamada T, Higaki A, et al. Synthetic DWI: contrast improvement for diffusion-weighted imaging in prostate using T1 shine-through by synthesizing images with adjusted TR and TE. MAGMA. 2025 Oct;38(5):771-780. doi: 10.1007/s10334-025-01243-5. PMID: 40126780. [doi][pmid]
2. Tamada T, Kojima Y, Kido A, et al. Comparison of calculated DWI and single-shot EPI DWI for prostate cancer detection at 3T. Proceedings of the 31th Annual Meeting of ISMRM, 2023 #1874.
3. Yu AC, Badve C, Ponsky LE, ey al. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer. Radiology. 2017 Jun;283(3):729-738. doi: 10.1148/radiol.2017161599. PMID: 28187264. [doi][pmid]
4. Panda A, Obmann VC, Lo WC, et al. MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland. Radiology. 2019 Sep;292(3):685-694. doi: 10.1148/radiol.2019181705. PMID: 31335285. [doi][pmid]
5. Panda A, OʼConnor G, Lo WC, et al. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping. Invest Radiol. 2019 Aug;54(8):485-493. doi: 10.1097/RLI.0000000000000569. PMID: 30985480. [doi][pmid]